Literature DB >> 27643930

Nrf2 as a key player of redox regulation in cardiovascular diseases.

M Barančík1, L Grešová, M Barteková, I Dovinová.   

Abstract

The oxidative stress plays an important role in the development of cardiovascular diseases (CVD). In CVD progression an aberrant redox regulation was observed. In this regulation levels of reactive oxygen species (ROS) play an important role in cellular signaling, where Nrf2 is the key regulator of redox homeostasis. Keap1-Nrf2-ARE system regulates a great set of detoxificant and antioxidant enzymes in cells after ROS and electrophiles exposure. In this review we focus on radical-generating systems in cardiovascular system as well as on Nrf2 as a target against oxidative stress and a key player of redox regulation in cardiovascular diseases. We also summarize the current knowledge about the role of Nrf2 in pathophysiology of several CVD (hypertension, cardiac hypertrophy, cardiomyopathies) as well as in cardioprotection against myocardial ischemia/ reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27643930     DOI: 10.33549/physiolres.933403

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  36 in total

1.  Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine.

Authors:  Ochuko L Erukainure; Omamuyovwi M Ijomone; Olakunle Sanni; Michael Aschner; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

Review 2.  Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential.

Authors:  Robert T Mallet; Eugenia B Manukhina; Steven Shea Ruelas; James L Caffrey; H Fred Downey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

3.  Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling.

Authors:  Md Jahangir Alam; Richa Gupta; Nitish R Mahapatra; Shyamal K Goswami
Journal:  Mol Cell Biochem       Date:  2019-12-02       Impact factor: 3.396

4.  Dysregulation of nuclear factor erythroid 2-related factor 2 signaling and activation of fibrogenic pathways in hearts of high fat diet-fed rats.

Authors:  Rania A Elrashidy
Journal:  Mol Biol Rep       Date:  2020-04-01       Impact factor: 2.316

Review 5.  New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.

Authors:  D Michaličková; M Šíma; O Slanař
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

Review 6.  The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.

Authors:  I Dovinova; M Kvandová; P Balis; L Gresova; M Majzunova; L Horakova; J Yh Chan; M Barancik
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

7.  Tanshinone I Inhibits Oxidative Stress-Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling.

Authors:  Yu-Ting Wu; Ling-Peng Xie; Yue Hua; Hong-Lin Xu; Guang-Hong Chen; Xin Han; Zhang-Bin Tan; Hui-Jie Fan; Hong-Mei Chen; Jun Li; Bin Liu; Ying-Chun Zhou
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

8.  Nrf2 inhibition induces oxidative stress, renal inflammation and hypertension in mice.

Authors:  Zeba Farooqui; Razia Sultana Mohammad; Mustafa F Lokhandwala; Anees Ahmad Banday
Journal:  Clin Exp Hypertens       Date:  2020-10-18       Impact factor: 1.749

Review 9.  Oxidative Stress and Hypertension.

Authors:  Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

10.  Lung Oxidative Stress, DNA Damage, Apoptosis, and Fibrosis in Adenine-Induced Chronic Kidney Disease in Mice.

Authors:  Abderrahim Nemmar; Turan Karaca; Sumaya Beegam; Priya Yuvaraju; Javed Yasin; Badreldin H Ali
Journal:  Front Physiol       Date:  2017-11-23       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.